000			02175 a2200673 4500
005			20250517211807.0
264		0	_c20190111
008			201901s 0 0 eng d
022			_a1879-0852
024	7		_a10.1016/j.ejca.2018.03.013 _2doi
040			_aNLM _beng _cNLM
100	1		_aJacquet, E
245	0	0	_aEndocrine therapy or chemotherapy as first-line therapy in hormone receptor-positive HER2-negative metastatic breast cancer patients. _h[electronic resource]
260			_bEuropean journal of cancer (Oxford, England : 1990) _c05 2018
300			_a93-101 p. _bdigital
500			_aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAged, 80 and over
650	0	4	_aAntineoplastic Agents, Hormonal _xtherapeutic use
650	0	4	_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use
650	0	4	_aAromatase Inhibitors _xtherapeutic use
650	0	4	_aBreast Neoplasms _xdrug therapy
650	0	4	_aBreast Neoplasms, Male _xdrug therapy
650	0	4	_aDatabases, Factual
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aNeoadjuvant Therapy
650	0	4	_aNeoplasm Metastasis
650	0	4	_aReceptor, ErbB-2 _xgenetics
650	0	4	_aRetrospective Studies
650	0	4	_aSurvival Analysis
650	0	4	_aYoung Adult
700	1		_aLardy-Cléaud, A
700	1		_aPistilli, B
700	1		_aFranck, S
700	1		_aCottu, P
700	1		_aDelaloge, S
700	1		_aDebled, M
700	1		_aVanlemmens, L
700	1		_aLeheurteur, M
700	1		_aGuizard, A V
700	1		_aLaborde, L
700	1		_aUwer, L
700	1		_aJacot, W
700	1		_aBerchery, D
700	1		_aDesmoulins, I
700	1		_aFerrero, J M
700	1		_aPerrocheau, G
700	1		_aCourtinard, C
700	1		_aBrain, E
700	1		_aChabaud, S
700	1		_aRobain, M
700	1		_aBachelot, T
773	0		_tEuropean journal of cancer (Oxford, England : 1990) _gvol. 95 _gp. 93-101
856	4	0	_uhttps://doi.org/10.1016/j.ejca.2018.03.013 _zAvailable from publisher's website
999			_c28287048 _d28287048